Finance entity
Every one of those 1 sits in a single category, markets. Apogee Therapeutics is most often covered alongside Arcturus Therapeutics, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.7 across the same-window beat baseline.
Last mentioned: Jul 28, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, markets. Apogee Therapeutics is most often covered alongside Arcturus Therapeutics, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.7 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 6.4 for that window. We currently track 1 Finance story that mention Apogee Therapeutics, all published on March 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 105 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Apogee Therapeutics. Shared-story counts are live from our verified record — not editorial picks.
A significant wave of analyst rating changes has hit the market, featuring a notable downgrade for boutique fitness giant Xponential Fitness and a bullish initiation for space leader Rocket Lab. These shifts underscore a broader institutional reassessment of growth trajectories across the fitness, aerospace, and biotechnology sectors.
Apogee Therapeutics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
